Volume 26, Issue 122, April 2022

Post covid-19 syndrome among recovered cohort during the convalescence: prospective study

Omer Quayid Kh Alanazi¹, Turki Ibrahim Al-khalaf², Saif Abdullah A AlQahtani³, Saif Marzouq Alanazi⁴, Ahmed M El-Malky⁵, Munirah Mohammed Mosa⁶, Ghada El Gohary⁷

¹Internship in Royal Medical Service, The School of Medicine & Surgery of Yarmouk University, Jordan
²Jordan University of Science and Technology, Medical Intern at PSMMC, Jordan
³MBBS Jordan University of Science and Technology, Home Health Care Physician Resident, King Fahad Medical City, Jordan
⁴Undergraduate Student, 6th year, Faculty of Medicine, Tabuk University, Saudi Arabia
⁵Public Health and Community Medicine Department, Theodor Bilharz Research Institute Academy of Scientific Research Cairo, Egypt; Morbidity and Mortality Review Unit, Deputy Supervisor, King Saud University Medical City, Riyadh, Saudi Arabia
⁶Department of obstetrics and Gynecology, College of medicine, King Saud University, King Saud University Medical City, Riyadh, Saudi Arabia
⁷Professor Hematology and Oncology, University oncology center, King Saud University Medical City, Saudi Arabia; Department of Medicine, Hematology/Oncology Division, College of Medicine, King Saud University, Saudi Arabia; Adult Hematolog / Stem Cell Transplant Unit, Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Egypt

ABSTRACT

Background: Hospitalization is not normally necessary in all COVID patients, nor is lab tests and PCR. There is subjective evidence that patients with "slight" COVID-19 may complain of persistent symptoms weeks after the infection. Methods: A group of 489 patients was tracked for 8 months after recovering from mild to severe COVID-19 infection at a Saudi tertiary hospital between March 6th and December 2nd 2021, IRB and informed permission acquired #89742/2022, and participation was freely. We evaluated the clinical condition, lab findings, and demographic features of the patients and used SPSSversion26 to perform our statistical analysis. Results: All of them were followed up until the second follow-up visit at 4.3 months (median 131 days (IQR 112-149). Age was a significant indicator of post CL syndrome, obtained p-value for age, 0.032, was less than critical alpha level of 0.05. BMI was a significant indicator of post CL syndrome, obtained p-value 0.032 (odds ratio (OR) 1.04;95% confidence interval (95% CI): (1.00 - 1.073)), body aches was a significant indicator of post CL syndrome, obtained p-value 0.040 (OR 0.59;95% CI (0.36-0.98)), fatigue was a significant indicator of post CL syndrome, obtained p-value .005 (OR 2.05; 95% CI (0.99-4.22)). Conclusion: Manifold signs are present around 3 months after the onset of signs in formerly hospitalized and non-hospitalized participants with established or suspected COVID-19. This suggests the presence of a "(post-COVID-19 syndrome)" and peaks the final healthcare needs in a subset of individuals with "slight" or "Spartan" COVID-19.

Keywords: Post Covid-19 Syndrome, Recovered, Cohort, Convalescence

Medical Science, 2022, 26, ms133e2156

PDF

DOI: https://doi.org/10.54905/disssi/v26i122/ms133e2156

Published: 12 April 2022